Table 4.
Associations of estradiol, follicle-stimulating hormone, progesterone, and testosterone with augmentation index.
| AIx% | Estradiol models [nmol/l] | FSH models [IU/l] | Progesterone models [nmol/l] | Testosterone models [nmol/l] | ||||
|---|---|---|---|---|---|---|---|---|
| B (SE) | 95% CI | B (SE) | 95% CI | B (SE) | 95% CI | B (SE) | 95% CI | |
| Univariable model | ||||||||
| Hormone | -1.69 (2.61) | -6.80 to 3.42 | 0.26 (0.03)*** | 0.21 to 0.31 | -0.08 (0.11) | -0.30 to 0.15 | 2.35 (3.41) | -4.34 to 9.03 |
| Multivariable model 1 | ||||||||
| Hormone | -2.26 (1.45) | -5.10 to 0.58 | 0.03 (0.04) | -0.04 to 0.11 | -0.16 (0.07)* | -0.30 to -0.02 | -0.24 (1.36) | -2.89 to 2.42 |
| Age | 0.94 (0.05)*** | 0.83 to 1.05 | 0.89 (0.11)*** | 0.68 to 1.09 | 0.94 (0.05)*** | 0.83 to 1.05 | 0.94 (0.05)*** | 0.84 to 1.05 |
| Multivariable model 2 | ||||||||
| Hormone | -2.29 (2.13) | -6.47 to 1.89 | 0.02 (0.03) | -0.04 to 0.08 | -0.07 (0.06) | -0.18 to 0.05 | 0.02 (1.30) | -2.53 to 2.53 |
| Age | 0.89 (0.07)*** | 0.75 to 1.03 | 0.82 (0.10)*** | 0.62 to 1.02 | 0.86 (0.07)*** | 0.71 to 1.00 | 0.85 (0.08)*** | 0.70 to 1.00 |
| V̇O2PEAK/FFM | 0.15 (0.12) | -0.08 to 0.38 | 0.17 (0.13) | -0.08 to 0.42 | 0.11 (0.13) | -0.14 to 0.35 | 0.19 (0.14) | -0.08 to 0.47 |
| Fat mass | -0.09 (0.16) | -0.41 to 0.23 | -0.03 (0.17) | -0.36 to 0.31 | -0.03 (0.18) | -0.38 to 0.33 | -0.01 (0.17) | -0.35 to 0.33 |
| MAP | 0.35 (0.06) *** | 0.22 to 0.47 | 0.37 (0.07) *** | 0.24 to 0.51 | 0.37 (0.06) *** | 0.25 to 0.49 | 0.39 (0.08)*** | 0.25 to 0.55 |
| HR | -0.34 (0.07)*** | -0.48 to -0.20 | -0.36 (0.08)*** | -0.52 to -0.20 | -0.34 (0.08)*** | -0.50 to -0.18 | -0.36 (0.09)*** | -0.54 to -0.18 |
*P ≤ 0.05; ***P ≤ 0.001. SE, standard error; CI, confidence interval; V̇O2PEAK, peak oxygen uptake; FFM, fat free mass; MAP, mean arterial pressure; HR, resting heart rate; FSH, follicle-stimulating hormone.